Pentoxifylline as an adjunctive in treatment of negative symptoms in chronic schizophrenia: A double-blind, randomized, placebo-controlled trial
- Type
- Retraction
- Notice date
- 3/11/2024 0:00
- Journal
- CNS Neuroscience & Therapeutics
- Publisher
- Wiley
- Notice DOI
- 10.1111/cns.14668
- Original paper DOI
- 10.1111/cns.14010
Reasons
- Concerns/Issues about Data
- Investigation by Journal/Publisher
- Unreliable Data
- Unreliable Results and/or Conclusions